Origin and Function of Circulating CD44 in Non-Hodgkin's Lymphoma

Journal of Immunology

Volumn 158, Issue 6, 1997, Pages 3000-3008

  Ristamäki, Raija ^a,b   Joensuu, Heikki ^c   Grön Virta, Kristiina ^a   Salmi, Marko ^a   Jalkanen, Sirpa ^a,d  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; HERMES ANTIGEN; HYALURONIC ACID;

ANIMAL; ARTICLE; BLOOD; BURKITT LYMPHOMA; CELL CULTURE; CHEMISTRY; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; LYMPH VESSEL ENDOTHELIUM; METABOLISM; MOLECULAR WEIGHT; MOUSE; MOUSE MUTANT; NONHODGKIN LYMPHOMA; PHYSIOLOGY; PROTEIN BINDING; TONSIL;

ANIMALS; ANTIGENS, CD44; BURKITT LYMPHOMA; ENDOTHELIUM, LYMPHATIC; FIBRONECTINS; HUMANS; HYALURONIC ACID; LYMPHOMA, NON-HODGKIN; MICE; MICE, SCID; MOLECULAR WEIGHT; PROTEIN BINDING; TONSIL; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0031569092     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Banks, R. E., A. J. H. Gearing, I. K. Hemingway, D. R. Norfolk, T. J. Perren, and P. J. Selby. 1993. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br. J. Cancer 68:122.
2. Tsujisaki, M., K. Imai, H. Hirata, Y. Hanzawa, J. Masuya, T. Nakano, T. Sugiyama, M. Matsui, Y. Hinoda, and A. Yachi. 1991. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin. Exp. Immunol. 85:3.
3. Harning, R., E. Mainolfi, J. C. Bystryn, M., Henn, V. J. Merluzzi, and R. Rothlein. 1991. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res. 51:5003.
4. Kageshita, T., A. Yoshii, T. Kimura, N. Kuriya, T. Ono, M. Tsujisaki, K. Imai, and S. Ferrone. 1993. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma. Cancer Res. 53:4927.
5. Christiansen, I., C. Cidlöf, A. C. Wallgren, B. Simonsson, and T. H. Tötterman. 1994. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. Blood 84:3030.
6. Spertini, O., P. Callegari, A.-S. Cordey, J. Hauert, J. Joggi, V. von Fliedner, and M. Schapira. 1994. High levels of the shed form of L-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium. Blood 84:1249.
7. Newman, W., L. D. Beall, C. W. Carson, G. G. Hunder, N. Graben, Z. I. Randhawa, T. V. Gopal, J. Wiener-Kronish, and M. A. Matthay. 1993. Soluble E-selectin is found in supernatants of activated endothelial cells and is elevated in the serum of patients with septic shock. J. Imnmnol. 150:644.
8. Spertini, O., B. Schleiffenbaum, C. White-Owen, P. Ruiz, Jr., and T. F. Tedder. 1992. ELISA for quantitation of L-selectin shed from leukocytes in vivo. J. Immunol. Methods 156:115.
9. Dalchau, R., J. Kirkley, and J. W. Fabre. 1980. Monoclonal antibody to a human brain-granulocyte-T lymphocyte antigen probably homologous to the W 3/13 antigen of the rat. Eur. J. Immunol. 10:745.
10. Telen, M. J., G. S. Eisenbarth, and B. F. Haynes. 1983. Human erythrocyte antigens: regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. J. Clin. Invest. 71:1878.
11. Lucas, M. G., A. M. Green, and M. J. Telen. 1989. Characterization of the serum In(Lu)-related antigen: identification of a serum protein related to erythrocyte p 80. Blood 73:596.
12. Haynes, B. F., L. P. Hale, K. L. Parton, M. E. Martin, and R. M. McCallum. 1991. Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Arthritis Rheum. 34:1434.
13. Butcher, E. C. 1986. The regulation of lymphocyte traffic. Curr. Top. Microbiol. Immunol. 128:85.
14. Haynes, B. F., M. J. Telen, L. P. Hale, and S. M. Denning. 1989. CD44: a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today 10:423.
15. Jalkanen, S., R. F. Bargatze, L. R. Herron, and E. C. Butcher. 1986. A lymphoid cell surface glycoprotein involved in endothelial cell recognition and lymphocyte homing in man. Eur. J. Immunol. 16:1195.
16. Omary, M. B., I. S. Trownbridge, M. Letarte, M. F. Kagnoff, and C. M. Isacke. 1988. Structural heterogeneity of human Pgp-1 and its relationship with p 85. Immunogenetics 27:460.
17. Brown, T. A., T. Bouchard, T. St. John, E. Wayner, and W. G. Carter. 1991. Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J. Cell Biol. 113: 207.
18. Screaton, G. R., M. V. Bell, D. G. Jackson, F. B. Cornelis, U. Gerth, and J. I. Bell. 1992. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 32 alternatively spliced exons. Proc. Natl. Acad. Sci. USA 89:12160.
19. Jalkanen, S., M. Jalkanen, R. Bargatze, M. Tammi, and E. C. Butcher. 1988. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J. Immunol. 141:1615.
20. Lesley, J., R. Hyman, and P. W. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271.
21. Aruffo, A., I. Stamenkovic, M. Melnick, C. B. Underhill, and B., Seed. 1990. CD44 is the principal cell surface receptor for hyaluronate. Cell 61:1303.
22. Miyake, K., C. B. Underhill, J. Lesley, and P. W. Kincade. 1990. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J. Exp. Med. 172:69.
23. Carter, W. G., and E. A. Wayner. 1988. Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J. Biol. Chem. 263:4193.
24. Jalkanen, S., H. Joensuu, K.-O. Söderström, and P. Klemi. 1991. Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma. J. Clin. Invest. 87: 1835.
25. Ristamäki, R., H. Joensuu, M. Salmi, and S. Jalkanen. 1994. Serum CD44 in malignant lymphoma: an association with treatment response. Blood 84:238.
26. Guo, Y. J., G. Liu, X. Wang, D. Jin, M. Wu, J. Ma, and M. S. Sy. 1994. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer. Cancer Res. 54:422.
27. Katoh, S., J. B. McCarthy, and P. W. Kincade. 1994. Characterization of soluble CD44 in the circulation of mice. J. Immunol. 153:3440.
28. Jalkanen, S., R. F. Bargatze, J. de los Toyos, and E. C. Butcher. 1987. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell Biol. 105:983.
29. Airas, L., M. Salmi, and S. Jalkanen. 1993. Lymphocyte-vascular adhesion protein-2 is a novel 70-kDa molecule involved in lymphocyte adhesion to vascular endothelium. J. Immunol. 151:4228.
30. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
31. Aho, R., S. Jalkanen, and H. Kalimo. 1994. CD44-hyaluronate interaction mediates in vitro lymphocyte binding to the white matter of the central nervous system. J. Neuropathol. Exp. Neurol. 53:295.
32. Jalkanen, S., and E. C. Butcher. 1985. In vitro analysis of the homing properties of human lymphocytes: Developmental regulation of functional receptors for high endothelial venules. Blood 66:577.
33. Krasagakis, K., C. Garbe, and C. E. Orfanos. 1993. Cytokines in human melanoma cells: synthesis, autocrine stimulation and regulatory functions. Melanoma Res. 3:425.
34. Hsu, S. M., J. W. Waldron, Jr., P. L. Hsu, and A. J. Hough, Jr. 1993. Cytokines in malignant lymphomas: review and prospective evaluation. Hum. Pathol. 24: 1040.
35. Bazil, V., and V. Horejsi. 1992. Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody simulating the effect of a natural receptor ligand. J. Immunol. 149:474.
36. Bartolazzi, A., R. Peach, A. Aruffo, and I. Stamenkovic. 1994. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J. Exp. Med. 180:53.
37. Knudson, C. B., and W. Knudson. 1990. Similar epithelial-stromal interactions in the regulation of hyaluronate production during limb morphogenesis and tumor invasion. Cancer Lett. 52:113.
38. Bertrand, P., N. Girard, B. Delpech, C. Duval, J. d'Anjou, and J. P. Dauce. 1992. Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int. J. Cancer 52:1.
39. Thomas, L., H. R. Byers, J. Vink, and I. Stamenkovic. 1992. CD44H regulates tumor cell migration on hyaluronate-coated substrate. J. Cell Biol. 118:971.
40. Yang, B., B. L. Yang, R. C. Savani, and E. A. Turley. 1994. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J. 13:286.
41. Lesley, J., N. Howes, A. Perschl, and R. Hyman. 1994. Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 180:383.
42. Tanaka, Y., D. H. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79.
43. Bennett, K. L., D. G. Jackson, J. C. Simon, E. Tanczos, R. Peach, B. Modrell, I. Stamenkovic, G. Plowman, and A. Aruffo. 1995. CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factor. J. Cell. Biol. 128:687.
44. Jalkanen, S., H. Joensuu, and P. Klemi. 1990. Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma. Blood 75: 1549.
45. Mali, M., H. Andtfolk, H. M. Miettinen, and M. Jalkanen. 1994. Suppression of tumor cell growth by syndecan-1 ectodomain. J. Biol. Chem. 269:27795.
46. Bazil, V., and J. L. Strominger. 1994. Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16. J. Immunol. 152:1314.
47. Campanero, M. R., R. Pulido, J. L., Alonso, J. P. Pivel, F. X. Pinebtel-Muinos, M. Fresno, and F. Sanchez-Madrid. 1991. Down-regulation by tumor necrosis factor-α of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism. Eur. J. Immunol. 21:3045.